HBK Sorce Advisory LLC Has $10.81 Million Stock Position in Procter & Gamble Company (The) $PG

HBK Sorce Advisory LLC decreased its stake in Procter & Gamble Company (The) (NYSE:PG) by 0.6% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 67,817 shares of the company’s stock after selling 416 shares during the period. HBK Sorce Advisory LLC’s holdings in Procter & Gamble were worth $10,805,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. B & T Capital Management DBA Alpha Capital Management grew its stake in shares of Procter & Gamble by 2.3% in the first quarter. B & T Capital Management DBA Alpha Capital Management now owns 2,795 shares of the company’s stock worth $476,000 after acquiring an additional 63 shares during the last quarter. Private Management Group Inc. boosted its stake in Procter & Gamble by 4.8% during the first quarter. Private Management Group Inc. now owns 1,384 shares of the company’s stock worth $236,000 after buying an additional 64 shares in the last quarter. Lantz Financial LLC boosted its stake in Procter & Gamble by 1.2% during the second quarter. Lantz Financial LLC now owns 5,237 shares of the company’s stock worth $834,000 after buying an additional 64 shares in the last quarter. Orca Investment Management LLC boosted its stake in Procter & Gamble by 2.0% during the second quarter. Orca Investment Management LLC now owns 3,238 shares of the company’s stock worth $516,000 after buying an additional 64 shares in the last quarter. Finally, Detalus Advisors LLC boosted its stake in Procter & Gamble by 0.8% during the first quarter. Detalus Advisors LLC now owns 7,918 shares of the company’s stock worth $1,349,000 after buying an additional 65 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

Wall Street Analysts Forecast Growth

PG has been the topic of a number of recent research reports. Evercore ISI reiterated an “in-line” rating and set a $170.00 price target (down previously from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. BNP Paribas Exane decreased their price target on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a research note on Tuesday, September 23rd. UBS Group decreased their price target on shares of Procter & Gamble from $180.00 to $176.00 and set a “buy” rating on the stock in a research note on Wednesday, October 8th. Wells Fargo & Company decreased their price target on shares of Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a research note on Thursday, September 25th. Finally, Raymond James Financial decreased their price target on shares of Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating on the stock in a research note on Monday, October 20th. Twelve research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $171.53.

Procter & Gamble Stock Down 1.8%

Shares of NYSE:PG opened at $148.63 on Thursday. Procter & Gamble Company has a 52 week low of $146.96 and a 52 week high of $180.43. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.51 and a current ratio of 0.71. The company’s fifty day moving average is $154.23 and its 200-day moving average is $158.09. The company has a market capitalization of $347.32 billion, a PE ratio of 21.70, a P/E/G ratio of 3.95 and a beta of 0.36.

Procter & Gamble (NYSE:PG) last issued its earnings results on Friday, October 24th. The company reported $1.99 EPS for the quarter, beating the consensus estimate of $1.90 by $0.09. Procter & Gamble had a net margin of 19.74% and a return on equity of 32.63%. The company had revenue of $22.39 billion for the quarter, compared to the consensus estimate of $22.23 billion. During the same quarter in the previous year, the company earned $1.93 EPS. The firm’s revenue for the quarter was up 3.0% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. Equities research analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, November 17th. Investors of record on Friday, October 24th will be given a dividend of $1.0568 per share. The ex-dividend date is Friday, October 24th. This represents a $4.23 annualized dividend and a yield of 2.8%. Procter & Gamble’s dividend payout ratio is 61.75%.

Insider Buying and Selling at Procter & Gamble

In related news, CFO Andre Schulten sold 11,638 shares of the company’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $1,830,308.26. Following the transaction, the chief financial officer owned 52,642 shares in the company, valued at $8,279,007.34. This represents a 18.11% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Gary A. Coombe sold 10,194 shares of the company’s stock in a transaction dated Thursday, August 21st. The stock was sold at an average price of $158.16, for a total transaction of $1,612,283.04. Following the transaction, the chief executive officer owned 34,978 shares in the company, valued at approximately $5,532,120.48. This trade represents a 22.57% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 149,763 shares of company stock worth $23,421,279 over the last quarter. Corporate insiders own 0.20% of the company’s stock.

Procter & Gamble Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.